AlloDirect Launches First Direct-to-Tissue-Bank Biologics Marketplace for Orthopedic Surgeons, ASCs, and Practices

New platform eliminates distributors from the allograft supply chain, connecting surgical facilities directly with AATB-certified tissue banks

CHICAGO, April 24, 2026 – AlloDirect, a new biologics procurement platform, has officially launched with a mission to fundamentally change how orthopedic surgeons, ambulatory surgery centers (ASCs), and practices source allograft tissue. The platform connects surgical facilities directly with AATB-accredited tissue banks, bypassing the distributor layer that has long defined biologics procurement.

For decades, sourcing allografts has required navigating a distribution network that adds cost, reduces transparency, and insulates facilities from direct knowledge of where their tissue came from and how it was processed. AlloDirect is built to address each of those friction points in a single platform.

How It Works

The AlloDirect catalog aggregates SKUs from multiple AATB-certified tissue banks in a single searchable interface. Materials managers and surgical coordinators can filter by graft type, size, indication, or donor criteria — and view live inventory availability across participating tissue banks side by side. Each tissue bank maintains its own storefront on the platform, giving buyers full visibility into who processed the graft, how it was recovered, and what compliance documentation supports it.

Ordering is completed in two clicks. Tissue ships directly from the bank to the facility. Every order includes end-to-end tracking and chain-of-custody documentation attached at the point of purchase — eliminating the follow-up typically required to obtain compliance records after the fact.

Who It’s Built For

AlloDirect is designed for ASCs, hospital-based surgical programs, and private orthopedic practices that manage their own biologics procurement. The platform is particularly suited to facilities with high allograft volume where procurement efficiency and cost visibility have direct operational impact.

“ASCs and practices can order directly from tissue banks. The supply chain for biologics doesn’t have to look the way it has for the last twenty years. AlloDirect is where procurement is headed.”

— Rhett Barker, Founder, AlloDirect

AlloDirect is live now at allo.direct. Orthopedic practices, ASCs, and surgery centers interested in evaluating the platform can access the marketplace directly through the site.

About AlloDirect

AlloDirect is a biologics procurement marketplace connecting orthopedic surgeons, ASCs, and surgical practices directly with AATB-certified tissue banks. The platform offers centralized catalog search, live inventory availability, direct ordering, end-to-end shipment tracking, and integrated chain-of-custody documentation. AlloDirect is headquartered in Chicago, Illinois and serves surgical facilities nationwide. Visit www.allo.direct to learn more